GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Hengqu® | SHR-8735
                                 hetrombopag is an approved drug (China (2021)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Hetrombopag is an orally bioavailable, non-peptide small‐molecule thrombopoietin receptor (TPOR/MPL) agonist, that was developed as a treatment for thrombocytopenia [1]. The parent compound is shown here. It is administered as the ethanolamine/olamine.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. China NMPA (2021) | 
| IUPAC Name  | 
| 5-[2-hydroxy-3-[[5-methyl-3-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-4-yl]diazenyl]phenyl]furan-2-carboxylic acid | 
| Synonyms  | 
| Hengqu® | SHR-8735 | 
| Database Links  | |
| CAS Registry No. | 1257792-41-8 | 
| GtoPdb PubChem SID | 404859104 | 
| PubChem CID | 135565610 | 
| Search Google for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N | 
| Search Google for chemicals with the same backbone | YATJUTCKRWETAB | 
| UniChem Compound Search for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |